Orbitofrontal dysfunction and medication overuse in patients with migraine

Headache

Volumn 52, Issue 10, 2012, Pages 1511-1519

  Biagianti, Bruno ^a   Grazzi, Licia ^b   Gambini, Orsola ^a   Usai, Susanna ^b   Muffatti, Riccardo ^c   Scarone, Silvio ^a   Bussone, Gennaro ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

Author keywords

chronic migraine; decision making; Iowa Gambling Task; medication overuse; orbitofrontal cortex

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DECISION MAKING; DRUG ABUSE; EPISODIC MIGRAINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBITAL CORTEX; ORBITOFRONTAL DYSFUNCTION; PRIORITY JOURNAL; TASK PERFORMANCE; TRANSFORMED MIGRAINE; TREATMENT OUTCOME;

CHRONIC MIGRAINE; DECISION MAKING; IOWA GAMBLING TASK; MEDICATION OVERUSE; ORBITOFRONTAL CORTEX;

ADULT; CHRONIC DISEASE; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES;

EID: 84869228270     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02277.x     Document Type: Article

References (37)

1. Diener HC, Katsarava Z, Limmroth V,. Headache attributed to a substance or its withdrawal. Handb Clin Neurol. 2010; 97: 589-599.
2. Evers S, Marziniak M,. Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol. 2010; 9: 391-401.
3. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary headache centre. Clinical characteristics and treatment outcomes. Cephalalgia. 2004; 24: 483-490.
4. Fumal A, Luareys S, Di Celemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550.
5. Schoenbaum G, Shaham Y,. The role of orbitofrontal cortex in drug addiction: A review of preclinical studies. Biol Psychiatry. 2008; 63: 256-262.
6. Crews FT, Boettiger CA,. Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav. 2009; 93: 237-247.
7. Dom G, Sabbe B, Hulstijn W, van den, Brink W,. Substance use disorders and the orbitofrontal cortex: Systematic review of behavioral decision-making and neuroimaging studies. Br J Psychiatry. 2005; 187: 209-220.
8. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA,. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry. 2003; 53: 65-74.
9. Bolla KI, Eldreth DA, London ED, et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage. 2003; 19: 1085-1094.
10. Radat F, Lanteri-Minet M,. What is the role of dependence-related behavior in medication-overuse headache? Headache. 2010; 50: 1597-1611.
11. Mongini F, Keller R, Deregibus A, Barbalonga E, Mongini T,. Frontal lobe dysfunction in patients with chronic migraine: A clinical-neuropsychological study. Psychiatry Res. 2005; 133: 101-106.
12. GÃmez-Beldarrain M, Carrasco M, Bilbao A, GarcÃa-Moncà JC,. Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse. J Headache Pain. 2011; 12: 459-466.
13. Austin MP, Ross M, Murray C, O'Carroll RE, Ebmeier KP, Goodwin GM,. Cognitive function in major depression. J Affect Disord. 1992; 25: 21-29.
14. Abbruzzese M, Ferri S, Scarone S,. Wisconsin Card Sorting Test performance in obsessive-compulsive disorder: No evidence for involvement of dorsolateral prefrontal cortex. Psychiatry Res. 1995; 58: 37-43.
15. Cavedini P, Riboldi G, Keller R, D'Annucci A, Bellodi L,. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry. 2002; 51: 334-341.
16. Breslau N, Davis GC, Schultz LR, Peterson EL,. Migraine and major depression: A longitudinal study. Headache. 1994; 34: 387-393.
17. Mongini F, Keller R, Deregibus A, Raviola F, Mongini T, Sancarlo M,. Personality traits, depression and migraine in women. A longitudinal study. Cephalalgia. 2003; 23: 186-192.
18. Stam AH, de Vries B, Janssens AC, et al. Shared genetic factor in migraine and depression: Evidence from a genetic isolate. Neurology. 2010; 74: 288-294.
19. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
20. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005; 25: 460-465.
21. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6: 278-296.
22. Hamilton M,. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32: 50-55.
23. Stewart WF, Lipton RB, Dowson AJ, Sawyer J,. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001; 56 (6 Suppl. 1): S20-S28.
24. D'Amico D, Mosconi P, Genco S, et al. The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia. 2001; 21: 947-952.
25. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J,. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90: 607-614.
26. Grande RB, Aaseth K, Saltyte Benth J, Gulbrandsen P, Russell MB, Lundqvist C,. The Severity of Dependence Scale detects people with medication overuse: The Akershus study of chronic headache. Neurol Neurosurg Psychiatry. 2009; 80: 784-789.
27. Lundqvist C, Benth JÅ, Grande RB, Aaseth K, Russell MB,. An adapted Severity of Dependence Scale is valid for the detection of medication overuse: The Akershus study of chronic headache. Eur J Neurol. 2011; 18: 512-518.
28. Lundqvist C, Aaseth K, Grande RB, Benth JS, Russell MB,. The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain. 2010; 148: 487-491.
29. Clark L, Bechara A, Damasio H, Aitken MR, Sahakian BJ, Robbin TW,. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision making. Brain. 2008; 131: 1311-1322.
30. Bechara A,. Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nat Neurosci. 2005; 8: 1458-1463.
31. Lipton RB,. Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology. 2009; 72 (5 Suppl.): S3-S7.
32. Valfre W, Rainero I, Bergui M, Pinessi L,. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache. 2008; 48: 109-117.
33. Grazzi L, Chiapparini L, Ferraro S, et al. Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: Clinical results and fMRI correlations. Headache. 2010; 50: 998-1004.
34. D'Andrea G, Leon A,. Pathogenesis of migraine: From neurotransmitters to neuromodulators and beyond. Neurol Sci. 2010; 31: S1-S7.
35. Andrasik F, Grazzi L, Usai S, D'Amico D, Kass S, Bussone G,. Disability in chronic migraine with medication overuse: Treatment effects at 3 years. Headache. 2007; 47: 1277-1281.
36. Loring DW, Williamson DJ, Meado KJ, Wiegand F, Hulihan J,. Topiramate dose effects on cognition: A randomized double-blind study. Neurology. 2011; 76: 131-137.
37. Zhang X, Shi J, Zhao LY, et al. Effects of stress on decision-making deficits in formerly heroin-dependent patients after different durations of abstinence. Am J Psychiatry. 2011; 168: 610-616.